Cargando…
Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease
Perfusion catheters have recently emerged as a novel approach to deliver liquid anti-proliferative agents into flow obstructed arterial segments. The purpose of this study was to determine the impact of luminal delivery pressure on liquid drug penetration into the vessel wall. An ex vivo model using...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455692/ https://www.ncbi.nlm.nih.gov/pubmed/34548563 http://dx.doi.org/10.1038/s41598-021-98063-z |
_version_ | 1784570725134237696 |
---|---|
author | Atigh, Marzieh K. Goel, Emily Erwin, Megan Greer, Ricky Ohayon, Jacques Pettigrew, Roderic I. Yazdani, Saami K. |
author_facet | Atigh, Marzieh K. Goel, Emily Erwin, Megan Greer, Ricky Ohayon, Jacques Pettigrew, Roderic I. Yazdani, Saami K. |
author_sort | Atigh, Marzieh K. |
collection | PubMed |
description | Perfusion catheters have recently emerged as a novel approach to deliver liquid anti-proliferative agents into flow obstructed arterial segments. The purpose of this study was to determine the impact of luminal delivery pressure on liquid drug penetration into the vessel wall. An ex vivo model using harvested porcine carotid arteries and a two-dimensional computational model were utilized to determine the impact of delivery pressure of liquid therapy into the arterial wall. A pig peripheral injury model determined the impact of intra-luminal delivery pressure on drug retention. Ex vivo results demonstrated that depth of fluid penetration varies from 6.93 ± 1.90% at 0 atm to 27.75 ± 6.61% penetration of the medial layer at 0.4 atm. Computational results had similar outcomes, as penetration varied between 4.4% and 22.84%. The in vivo results demonstrated significant increase in drug delivery to the arterial tissue at 0.4 atm versus 0.1 atm at 1 h (23.43 ± 13.59 ng/mg vs. 2.49 ± 1.81 ng/mg, p = 0.026) and 7 days (0.50 ± 0.39 ng/mg vs. 0.018 ± 0.023 ng/mg, p = 0.0496). The result of this study provides an innovative strategic and technical approach to enable targeted liquid therapy. |
format | Online Article Text |
id | pubmed-8455692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84556922021-09-24 Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease Atigh, Marzieh K. Goel, Emily Erwin, Megan Greer, Ricky Ohayon, Jacques Pettigrew, Roderic I. Yazdani, Saami K. Sci Rep Article Perfusion catheters have recently emerged as a novel approach to deliver liquid anti-proliferative agents into flow obstructed arterial segments. The purpose of this study was to determine the impact of luminal delivery pressure on liquid drug penetration into the vessel wall. An ex vivo model using harvested porcine carotid arteries and a two-dimensional computational model were utilized to determine the impact of delivery pressure of liquid therapy into the arterial wall. A pig peripheral injury model determined the impact of intra-luminal delivery pressure on drug retention. Ex vivo results demonstrated that depth of fluid penetration varies from 6.93 ± 1.90% at 0 atm to 27.75 ± 6.61% penetration of the medial layer at 0.4 atm. Computational results had similar outcomes, as penetration varied between 4.4% and 22.84%. The in vivo results demonstrated significant increase in drug delivery to the arterial tissue at 0.4 atm versus 0.1 atm at 1 h (23.43 ± 13.59 ng/mg vs. 2.49 ± 1.81 ng/mg, p = 0.026) and 7 days (0.50 ± 0.39 ng/mg vs. 0.018 ± 0.023 ng/mg, p = 0.0496). The result of this study provides an innovative strategic and technical approach to enable targeted liquid therapy. Nature Publishing Group UK 2021-09-21 /pmc/articles/PMC8455692/ /pubmed/34548563 http://dx.doi.org/10.1038/s41598-021-98063-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Atigh, Marzieh K. Goel, Emily Erwin, Megan Greer, Ricky Ohayon, Jacques Pettigrew, Roderic I. Yazdani, Saami K. Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease |
title | Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease |
title_full | Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease |
title_fullStr | Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease |
title_full_unstemmed | Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease |
title_short | Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease |
title_sort | precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455692/ https://www.ncbi.nlm.nih.gov/pubmed/34548563 http://dx.doi.org/10.1038/s41598-021-98063-z |
work_keys_str_mv | AT atighmarziehk precisiondeliveryofliquidtherapyintothearterialwallforthetreatmentofperipheralarterialdisease AT goelemily precisiondeliveryofliquidtherapyintothearterialwallforthetreatmentofperipheralarterialdisease AT erwinmegan precisiondeliveryofliquidtherapyintothearterialwallforthetreatmentofperipheralarterialdisease AT greerricky precisiondeliveryofliquidtherapyintothearterialwallforthetreatmentofperipheralarterialdisease AT ohayonjacques precisiondeliveryofliquidtherapyintothearterialwallforthetreatmentofperipheralarterialdisease AT pettigrewroderici precisiondeliveryofliquidtherapyintothearterialwallforthetreatmentofperipheralarterialdisease AT yazdanisaamik precisiondeliveryofliquidtherapyintothearterialwallforthetreatmentofperipheralarterialdisease |